Sana Biotechnology, Inc.·4

Sep 16, 6:52 PM ET

Cassidy Bernard J 4

4 · Sana Biotechnology, Inc. · Filed Sep 16, 2022

Insider Transaction Report

Form 4
Period: 2022-09-15
Cassidy Bernard J
EVP & General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-09-15+800,000800,000 total
    Exercise: $7.13Exp: 2032-09-14Common Stock (800,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable as to 25% of the underlying shares on September 15, 2023 and in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT